Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

29.00
-0.6400-2.16%
Post-market: 29.030.0300+0.10%16:04 EDT
Volume:37.02K
Turnover:1.07M
Market Cap:18.85M
PE:- -
High:29.68
Open:29.68
Low:28.35
Close:29.64
52wk High:31.65
52wk Low:13.42
Shares:650.00K
Float Shares:650.00K
Volume Ratio:3.29
T/O Rate:5.69%
Dividend:0.24
Dividend Rate:0.83%
ROE:--
ROA:--
PB:0.43
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.